Track Sotera Health Company — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Sotera Health Company SHC · Stock Open Sotera Health Company in new tab

16.61 USD
P/E
27.17
EPS
0.60
P/B
6.35
ROE
27.03
Beta
1.93
Target Price
21.44 USD
Loading chart...
Key Metrics
Earnings dateFeb. 23, 2027
P/E27.17
EPS0.60
Book Value2.57
Price to Book6.35
Debt/Equity310.41
% Insiders2.408%
Growth
Revenue Growth0.04%
Earnings Growth0.18%
Estimates
Forward P/E15.31
Forward EPS1.07
Target Mean Price21.44

DCF valuation

Model fair value for Sotera Health Company (SHC)
Result
Sign in to run the valuation for SHC.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
mean target 21.44 USD (low 15.00, high 25.00)
Low 15.00
Mean 21.44
High 25.00
Price 16.61
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Sotera Health Company Logo Sotera Health Company Analysis (SHC)

United States Health Care Official Website Stock

Is Sotera Health Company a good investment? Sotera Health Company (SHC) is currently trading at 16.61 USD. Market analysts have a consensus price target of 21.44 USD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 27.17. This valuation is generally in line with the broader market.

Earnings Schedule: Sotera Health Company is expected to release its next earnings report on Feb. 23, 2027. The market consensus estimate for Forward EPS is 1.07.

Investor FAQ

Does Sotera Health Company pay a dividend?

No, it does not currently pay a dividend.

What asset class is Sotera Health Company?

Sotera Health Company is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Feb. 23, 2027. The company currently has a trailing EPS of 0.60.

Company Profile

Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for medical devices, pharmaceutical, and food safety and advanced applications markets. The Nordion segment provides Cobalt-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. It also offers gamma irradiation systems. The Nelson Labs segment provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.

Exchange Ticker
NMS (United States) SHC
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion